How can we better meet the needs of living kidney donors? A recent study in Kidney International underscores the importance of a collaborative framework to enhance care for LKDs. bit.ly/KN160835

To kick off this special issue on toxicology and kidney health, Linda Awdishu discusses the vital role of nephrologists in drug safety to maximize efficacy and reduce adverse effects. bit.ly/KN160813

Individuals with kidney diseases are especially susceptible to the effects of environmental toxins and pollutants. Environmental justice is crucial to examining these health effects and initiating efforts to mitigate exposure. bit.ly/KN160815

Only two weeks left to submit your late-breaking clinical trial for #KidneyWk! This year's meeting features multiple oral sessions and more presentation time for high-impact research. Share your Phase 2, 3, or 4 clinical trial today. Get started: asn.kdny.info/wqL350SxVm5

Perinatal exposure to environmental toxins is linked with risk of CKD and/or hypertension in adulthood. Addressing this issue requires a multifaceted approach guided by research initiatives and legislation. bit.ly/KN160816 Rahul Chanchlani Jhanahan Sriranjan (He/Him)

Ingestion or inhalation of paraquat is a significant health concern, especially in agricultural communities. What should nephrologists know about this highly potent herbicide? bit.ly/KN160817 Dr. Divya Bajpai 🇮🇳

Intermittent hemodialysis, using high-efficiency and high-flux biocompatible synthetic membranes, is the most common extracorporeal modality used for poisoning treatment. bit.ly/KN160818 Mythri Shankar 🇮🇳

Private equity, AI, technology companies, and value-based care influence the direction of patient care and research. In this business round-up, deepen your understanding of the changing landscape in kidney care from the first half of the year. bit.ly/KN160808

Approximately 5.4 million people worldwide are bitten by snakes each year, resulting in 1.8 to 2.7 million envenomations and 140,000 deaths. How does snake envenoming "bite" the kidneys? bit.ly/KN160820 Sachin Naik Dr. Divya Bajpai 🇮🇳

"Together, American Society of Nephrology and the rest of the kidney community will need to adapt to navigate the future, ideally shaping the best outcome for the millions of people living with kidney diseases." Tod Ibrahim poses potential scenarios for nephrology's future. bit.ly/KN160810

Herbal and dietary supplements promise many health benefits, but they can pose significant risks to kidney health. Addressing these "hidden dangers" requires a multifaceted approach, including increased regulation and education. bit.ly/KN160822 Rolando Claure, MD, FASN, FISN 🇧🇴

In June, the House unveiled an appropriations bill featuring ASN policy victories, alongside cuts and reforms including restructuring the NIH. bit.ly/KN160824 Earlier this month, ASN Advocacy commented on the restructuring, reflected in the bill. bit.ly/4dFoE2H

Recent analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort offers insights into the unique experiences of individuals with rare kidney diseases, emphasizing the need for targeted research and specialized care. bit.ly/KN160827 divya monga

A study in JAMA Network Open reports that fewer than one-fourth of patients with type 2 diabetes undergo recommended screening for CKD. bit.ly/KN160828a

ICYMI: This issue's special section features leading perspectives on the intersection of toxicology and kidney health—from pharmacokinetics to environmental toxin exposure to herbal supplements. bit.ly/KN160813a

Among patients with CKD, the risk of atheromatous cardiovascular disease is lower in women compared with men, whereas non-ACVD risk does not vary by sex, reports a study in Amanda Kirwan🇪🇺🇺🇦. bit.ly/KN160828b

PARASOL, a community collaboration, is making strides toward defining a surrogate endpoint for use in FSGS clinical trials, which would enable the development of safe and effective therapies for people with this rare but devasting glomerular disorder. bit.ly/KN160833

Intravenous amino acid infusion reduces the risk of AKI associated with cardiac surgery, reports a clinical trial in NEJM. bit.ly/KN160830a

A recent study in NDT highlights the need for regular medication review along with new interventions to reduce polypharmacy for patients on dialysis. bit.ly/KN160831